Items where authors include "Deane, J."

Jump to: Article
Number of items: 7.

Article

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Sandercock, P., Darbyshire, J., DeMets, D. et al. (2050 more authors) (2024) Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature Communications, 15. 924. ISSN 2041-1723

Rangelov, B. orcid.org/0000-0001-7017-1575, Young, A. orcid.org/0000-0002-7772-781X, Lilaonitkul, W. et al. (145 more authors) (2023) Author Correction: Delineating COVID-19 subgroups using routine clinical data identifies distinct in-hospital outcomes. Scientific Reports, 13. 18376. ISSN 2045-2322

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Rangelov, B. orcid.org/0000-0001-7017-1575, Young, A. orcid.org/0000-0002-7772-781X, Lilaonitkul, W. et al. (97 more authors) (2023) Delineating COVID-19 subgroups using routine clinical data identifies distinct in-hospital outcomes. Scientific Reports, 13. 9986. ISSN 2045-2322

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

This list was generated on Tue Apr 1 19:50:21 2025 BST.